Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Eli Lily
Sort By
Newest First
1 / 1
1 / 1
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08
Jun 24, 2022
Migraines
REYVOW Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase Study
Eli Lilly and Company
PR-M09-20-22
Sep 18, 2020
Expanded Capacity
Eli Lilly Expands Insulin Production Capacity in Indiana
Nice Insight
PAO-M11-17-NI-018
Nov 10, 2017
